Cyclin-Dependent Kinase-5/p35 Phosphorylates Presenilin 1 to Regulate Carboxy-Terminal Fragment Stability

Ahlijanian, 2000, Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5, Proc. Natl. Acad. Sci. USA, 87, 2910, 10.1073/pnas.040577797 Bajaj, 1998, Cyclin-dependent kinase-5 is associated with lipofuscin in motor neurones in amyotrophic lateral sclerosis, Neurosci. Lett., 245, 45, 10.1016/S0304-3940(98)00176-1 Baumann, 1997, Distinct processing of endogenous and overexpressed recombinant presenilin 1, Neurobiol. Aging, 18, 181, 10.1016/S0197-4580(97)00004-3 Beaudette, 1993, Substrate specificity characterization of a cdc2-like protein kinase purified from bovine brain, J. Biol. Chem., 268, 20825, 10.1016/S0021-9258(19)36859-0 Brownlees, 2000, Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase- 1b/Jun N-terminal kinase-3, J. Cell Sci., 113, 401, 10.1242/jcs.113.3.401 Capell, 1998, The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex, J. Biol. Chem., 273, 3205, 10.1074/jbc.273.6.3205 Checler, 2001, The multiple paradoxes of presenilins, J. Neurochem., 76, 1621, 10.1046/j.1471-4159.2001.00244.x De Strooper, 1997, Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins, J. Biol. Chem., 272, 3590, 10.1074/jbc.272.6.3590 Dhavan, 2001, A decade of cdk5, Nature Rev. Mol. Cell Biol., 2, 749, 10.1038/35096019 Fraser, 2000, Presenilin structure, function and role in Alzheimer disease, Biochim. Biophys. Acta, 1502, 1, 10.1016/S0925-4439(00)00028-4 Guidato, 1996, Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cyclin-dependent kinase-5, J. Neurochem., 66, 1698, 10.1046/j.1471-4159.1996.66041698.x Irving, 1997, Tau phosphorylation in cells transfected with wild-type or an Alzheimer's disease mutant Presenilin-1, Neurosci. Lett., 222, 71, 10.1016/S0304-3940(97)13343-2 Kesavapany, 2001, p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction, Eur. J. Neurosci., 13, 241 Kirschenbaum, 2001, Glycogen synthase kinase-3β regulates presenilin 1 C-terminal fragment levels, J. Biol. Chem., 276, 30701, 10.1074/jbc.M102849200 Kirschenbaum, 2000, Substitution of a GSK-3beta phosphorylation site in presenilin 1 separates presenilin function from β-catenin signaling, J. Biol. Chem., 276, 7366, 10.1074/jbc.M004697200 Lau, 2000, X11α and X11β interact with presenilin-1 via their PDZ domains, Mol. Cell. Neurosci., 16, 555, 10.1006/mcne.2000.0898 Lee, 2000, Neurotoxicity induces cleavage of p35 to p25 by calpain, Nature, 405, 360, 10.1038/35012636 Mercken, 1996, Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing, FEBS Lett., 389, 297, 10.1016/0014-5793(96)00608-4 Nguyen, 2001, Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions, Neuron, 30, 135, 10.1016/S0896-6273(01)00268-9 Patrick, 1999, Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration, Nature, 402, 615, 10.1038/45159 Ratovitski, 1997, Endoproteolytic processing and stabilization of wild-type and mutant presenilin, J. Biol. Chem., 272, 24536, 10.1074/jbc.272.39.24536 Seeger, 1997, Evidence for phosphorylation and oligomeric assembly of presenilin 1, Proc. Natl. Acad. Sci. USA, 94, 5090, 10.1073/pnas.94.10.5090 Shetty, 1993, cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: Isolation and characterization, Proc. Natl. Acad. Sci. USA, 90, 6844, 10.1073/pnas.90.14.6844 Small, 2001, The role of presenilins in gamma-secretase activity: Catalyst or cofactor?, J. Neurochem., 76, 1612, 10.1046/j.1471-4159.2001.00246.x Steiner, 1998, Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation, J. Biol. Chem., 273, 32322, 10.1074/jbc.273.48.32322 Sun, 1996, Phosphorylation of the high molecular weight neurofilament protein (NF-H) by cdk-5 and p35, J. Biol. Chem., 271, 14245, 10.1074/jbc.271.24.14245 Thinakaran, 1996, Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo, Neuron, 17, 181, 10.1016/S0896-6273(00)80291-3 Tomita, 2001, The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation and γ-secretase activities of presenilins, J. Biol. Chem., 276, 33273, 10.1074/jbc.M011152200 Tsai, 1994, p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5, Nature, 371, 419, 10.1038/371419a0 Tsai, 1993, Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system, Development, 119, 1029, 10.1242/dev.119.4.1029 Walter, 1997, Proteolytic processing of the Alzheimer disease-associated presenilin-1 generates an in vivo substrate for protein kinase C, Proc. Natl. Acad. Sci. USA, 94, 5349, 10.1073/pnas.94.10.5349 Walter, 1998, Proteolytic fragments of the Alzheimer's disease associated presenilins-1 and -2 are phosphorylated in vivo by distinct cellular mechanisms, Biochemistry, 37, 5961, 10.1021/bi971763a Wolfe, 2001, Presenilin and gamma-secretase: Structure meets function, J. Neurochem., 76, 1615, 10.1046/j.1471-4159.2001.00245.x Yu, 1998, The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin, J. Biol. Chem., 273, 16470, 10.1074/jbc.273.26.16470